ClinicalTrials.Veeva

Menu

Ex Vivo Study of the Heracure Device for Intra-uterine Morcellation After Vaginal or Laparoscopic Hysterectomy

H

Heracure Medical

Status

Unknown

Conditions

Vaginal or Laparoscopic Hysterectomy

Treatments

Device: Heracure Device

Study type

Interventional

Funder types

Industry

Identifiers

NCT05332132
202019038

Details and patient eligibility

About

Safety and performance evaluation of the Heracure Device for intra-uterine morcellation after vaginal or laparoscopic hysterectomy.

Full description

The purpose of this clinical investigation is to evaluate the safety and efficacy of the Heracure Device for intra-uterine morcellation after vaginal or laparoscopic hysterectomy.

Enrollment

10 estimated patients

Sex

Female

Ages

21+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subject is undergoing hysterectomy due to benign gynecologic disease

Exclusion criteria

  • Subject is not suspected of malignancy

Trial design

Primary purpose

Device Feasibility

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Intrauterine Morcellation of Uteri Post-Surgery
Experimental group
Description:
Intrauterine Morcellation of Uteri Post-Surgery (Ex Vivo Study)
Treatment:
Device: Heracure Device

Trial contacts and locations

1

Loading...

Central trial contact

Gal Meister

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems